Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
180 Life Sciences Corp. (KBLM)
|
Add to portfolio |
|
|
|
| Price: |
$3.90
| | Metrics |
| OS: |
5.32
|
M
| |
|
|
| Market cap: |
$20.7
|
M
| |
|
|
|
Net cash:
|
$1.39
|
M
| |
$0.26
|
per share
|
|
EV:
|
$19.3
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
| Research and development | 2.2 | 1.0 | | | | |
| General and administrative | 15.5 | 11.7 | | 1.2 | 0.6 | 0.3 |
| EBITA | -20.7 | -14.4 | | -1.2 | -0.6 | -0.3 |
| Amortization of intangibles | 0.1 | 0.1 | | | | |
| EBIT | -20.8 | -14.6 | | -1.2 | -0.6 | -0.3 |
| Pre-tax income | -39.7 | -20.3 | | 0.2 | 1.5 | 0.3 |
| Income taxes | -0.9 | 0.0 | | 0.3 | 0.4 | 0.2 |
| Tax rate | 2.4% | 0.1% | | 155.0% | 28.4% | 61.2% |
| Net income | -38.7 | -20.3 | | -0.1 | 1.0 | 0.1 |
| |
| Diluted EPS | ($20.38) | ($12.96) | | ($0.02) | $0.07 | $0.01 |
| Shares outstanding (diluted) | 1.9 | 1.6 | | 4.2 | 14.9 | 9.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|